Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

This study has suspended participant recruitment.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) ) Identifier:
First received: January 29, 2011
Last updated: October 8, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: June 2020
  Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)